Rocío L Molinero, Katherine S Hermida Alava, Tomás Brito Devoto, Francisco Sautua, Marcelo Carmona, María L Cuestas, Gabriela A Pena
{"title":"Prevalence of azole-resistant Aspergillus fumigatus and other aspergilli in the environment from Argentina.","authors":"Rocío L Molinero, Katherine S Hermida Alava, Tomás Brito Devoto, Francisco Sautua, Marcelo Carmona, María L Cuestas, Gabriela A Pena","doi":"10.1093/mmy/myae098","DOIUrl":null,"url":null,"abstract":"<p><p>Azole resistance has emerged as a new therapeutic challenge in patients with aspergillosis. Various resistance mutations are attributed to the widespread use of triazole-based fungicides in agriculture. This study explored the prevalence of azole-resistant Aspergillus fumigatus (ARAF) and other aspergilli in the Argentine environment. A collection of A. fumigatus and other aspergilli strains isolated from soil of growing crops, compost, corn, different animal feedstuffs, and soybean and chickpea seeds were screened for azole resistance. No ARAF was detected in any of the environmental samples studied. However, five A. flavus, one A. ostianus, one A. niger and one A. tamarii recovered from soybean and chickpea seeds showed reduced susceptibility to medical azole antifungals (MAA). The susceptibility profiles of five A. flavus isolates, showing reduced susceptibility to demethylase inhibitors (DMIs), were compared with those of 10 isolates that exhibited susceptibility to MAA. Aspergillus flavus isolates that showed reduced MAA susceptibility exhibited different susceptibility profiles to DMIs. Prothioconazole and tebuconazole were the only DMIs significantly less active against isolates with reduced susceptibility to MAA. Although no ARAF isolates were found in the samples analysed, other aspergilli with reduced susceptibility profile to MAA being also important human pathogens causing allergic, chronic and invasive aspergillosis, are present in the environment in Argentina. Although a definitive link between triazole-based fungicide use and isolation of azole-resistant human pathogenic aspergilli from agricultural fields in Argentina remains elusive, this study unequivocally highlights the magnitude of the environmental spread of azole resistance among other Aspergillus species.</p>","PeriodicalId":18586,"journal":{"name":"Medical mycology","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical mycology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/mmy/myae098","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Azole resistance has emerged as a new therapeutic challenge in patients with aspergillosis. Various resistance mutations are attributed to the widespread use of triazole-based fungicides in agriculture. This study explored the prevalence of azole-resistant Aspergillus fumigatus (ARAF) and other aspergilli in the Argentine environment. A collection of A. fumigatus and other aspergilli strains isolated from soil of growing crops, compost, corn, different animal feedstuffs, and soybean and chickpea seeds were screened for azole resistance. No ARAF was detected in any of the environmental samples studied. However, five A. flavus, one A. ostianus, one A. niger and one A. tamarii recovered from soybean and chickpea seeds showed reduced susceptibility to medical azole antifungals (MAA). The susceptibility profiles of five A. flavus isolates, showing reduced susceptibility to demethylase inhibitors (DMIs), were compared with those of 10 isolates that exhibited susceptibility to MAA. Aspergillus flavus isolates that showed reduced MAA susceptibility exhibited different susceptibility profiles to DMIs. Prothioconazole and tebuconazole were the only DMIs significantly less active against isolates with reduced susceptibility to MAA. Although no ARAF isolates were found in the samples analysed, other aspergilli with reduced susceptibility profile to MAA being also important human pathogens causing allergic, chronic and invasive aspergillosis, are present in the environment in Argentina. Although a definitive link between triazole-based fungicide use and isolation of azole-resistant human pathogenic aspergilli from agricultural fields in Argentina remains elusive, this study unequivocally highlights the magnitude of the environmental spread of azole resistance among other Aspergillus species.
唑类抗药性已成为曲霉菌病患者在治疗上面临的新挑战。各种抗性突变都是由于三唑类杀菌剂在农业中的广泛使用造成的。本研究探讨了阿根廷环境中抗唑曲霉菌(ARAF)和其他曲霉菌的流行情况。研究人员对从生长作物的土壤、堆肥、玉米、不同的动物饲料、大豆和鹰嘴豆种子中分离出来的烟曲霉和其他曲霉菌株进行了抗唑性筛选。在所研究的环境样本中均未检测到 ARAF。不过,从大豆和鹰嘴豆种子中发现的五种黄曲霉、一种奥氏黄曲霉、一种黑曲霉和一种塔玛氏黄曲霉对医用唑类抗真菌药(MAA)的敏感性降低。将对脱甲基酶抑制剂(DMIs)敏感性降低的 5 个黄曲霉分离物的敏感性特征与对 MAA 敏感的 10 个分离物的敏感性特征进行了比较。对 MAA 药敏性降低的黄曲霉分离物对 DMIs 的药敏性表现出不同的特征。丙硫菌唑和戊唑醇是唯一对 MAA 敏感性降低的分离物活性显著降低的 DMIs。虽然在分析的样本中没有发现 ARAF 分离物,但阿根廷环境中还存在对 MAA 敏感性降低的其他曲霉菌,它们也是导致过敏性、慢性和侵袭性曲霉菌病的重要人类病原体。虽然三唑类杀菌剂的使用与从阿根廷农田中分离出抗偶氮唑人类致病曲霉菌之间的明确联系仍难以确定,但本研究明确强调了抗偶氮唑曲霉菌在其他曲霉菌中的环境传播规模。
期刊介绍:
Medical Mycology is a peer-reviewed international journal that focuses on original and innovative basic and applied studies, as well as learned reviews on all aspects of medical, veterinary and environmental mycology as related to disease. The objective is to present the highest quality scientific reports from throughout the world on divergent topics. These topics include the phylogeny of fungal pathogens, epidemiology and public health mycology themes, new approaches in the diagnosis and treatment of mycoses including clinical trials and guidelines, pharmacology and antifungal susceptibilities, changes in taxonomy, description of new or unusual fungi associated with human or animal disease, immunology of fungal infections, vaccinology for prevention of fungal infections, pathogenesis and virulence, and the molecular biology of pathogenic fungi in vitro and in vivo, including genomics, transcriptomics, metabolomics, and proteomics. Case reports are no longer accepted. In addition, studies of natural products showing inhibitory activity against pathogenic fungi are not accepted without chemical characterization and identification of the compounds responsible for the inhibitory activity.